Results 281 to 290 of about 2,123,606 (402)
Therapeutic Application of Noncytotoxic Molecular Targeted Therapy in Gliomas: Growth Factor Receptors and Angiogenesis Inhibitors [PDF]
, 2008 Ahmed Idbaïh +4 more
openalex +1 more source
Molecular Oncology, EarlyView.Chronic TGF‐β exposure drives epithelial HCC cells from a senescent state to a TGF‐β resistant mesenchymal phenotype. This transition is characterized by the loss of Smad3‐mediated signaling, escape from senescence, enhanced invasiveness and metastatic potential, and upregulation of key resistance modulators such as MARK1 and GRM8, ultimately promoting
Minenur Kalyoncu +11 more
wiley +1 more source
Dementia incidence varied by anticancer drugs and molecular targeted therapy in a population-based cohort study. [PDF]
Sci RepLee EH +5 more
europepmc +1 more source
Molecularly Targeted Therapy for Lung Cancer: Recent Topics [PDF]
, 2008 Nagahiro Saijo
openalex +1 more source
MET-dependent solid tumours — molecular diagnosis and targeted therapy
Nature Reviews Clinical Oncology, 2020 Robin Guo +5 more
semanticscholar +1 more source
Molecular Oncology, EarlyView.We identified adaptor protein ShcD as upregulated in triple‐negative breast cancer and found its expression to be correlated with reduced patient survival and increased invasion in cell models. Using a proteomic screen, we identified novel ShcD binding partners involved in EGFR signaling pathways.
Hayley R. Lau +11 more
wiley +1 more source
Long-term survival following molecular-targeted therapy for intramedullary non-small-cell lung cancer metastasis. [PDF]
Surg Neurol IntKanematsu R +4 more
europepmc +1 more source
Profiling of a novel circadian clock-related prognostic signature and its role in immune function and response to molecular targeted therapy in pancreatic cancer. [PDF]
Aging (Albany NY), 2023 Jin Y, Gong S, Shang G, Hu L, Li G.
europepmc +1 more source